Publication Results (774)

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• »

• Identification of incident pancreatic cancer in Ontario administrative health data: a validation study

  Wu JW, Azoulay L, Huang A, Paterson M, Wu F, Secrest MH, Filion KB. Pharmacoepidemiol Drug Saf. 2018; Oct 4 [Epub ahead of print].

• Patient-reported symptoms after breast cancer diagnosis and treatment: a retrospective cohort study

  Davis LE, Bubis LD, Mahar AL, Li Q, Sussman J, Moody L, Barbera L, Holloway CM, Coburn NG. Eur J Cancer. 2018; 101:1-11. Epub 2018 Jul 12.

• Elevated risk of cancer following solid organ transplant in childhood: a population-based cohort study

  Kitchlu A, Dixon S, Dirk JS, Chanchlani R, Vasilevska-Ristovska J, Borges K, Dipchand AI, Ng VL, Hebert D, Solomon M, Paterson JM, Gupta S, Kim SJ, Nathan PC, Parekh RS. Transplantation. 2019; 103(3):588-96. Epub 2018 Jul 25.

• Outcomes in elderly patients following surgery for colorectal cancer in the veterans affairs health care system

  Rabeneck L, Davila J, Thompson M, El-Serag HB. Aliment Pharmacol Ther. 2004; 20(10):1115-24.

• Depressive symptoms as a determinant of breast and cervical cancer screening in women: a population-based study in Ontario, Canada

  Vigod SN, Kurdyak PA, Stewart DE, Gnam WH, Goering PN. Arch Womens Ment Health. 2001; 14(2):159-68. Epub 2011 Feb 11.

• Interval colorectal cancers following guaiac fecal occult blood testing in the Ontario ColonCancerCheck program

  Paszat L, Sutradhar R, Tinmouth J, Baxter N, Rabeneck L. Can J Gastroenterol Hepatol. 2016; 2016:4768728. Epub 2016 May 8.

• Patterns of care in the initial management of women with ovarian cancer in Ontario

  Elit L, Schultz S, Prysbysz R, Saskin R, Gunraj N, Wilton AS, Simunovic M, Urbach D. Eur J Gynaecol Oncol. 2009; 30(4):361-4.

• Symptom burden and performance status in a population-based cohort of ambulatory cancer patients

  Barbera L, Seow H, Howell D, Sutradhar R, Earle C, Liu Y, Stitt A, Husain A, Sussman J, Dudgeon D. Cancer. 2010; 116(24):5767-76. Epub 2010 Nov 8.

• Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut

  Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ. BMJ. 2002; 325(7367):740.

• The effect of vasectomy reversal on prostate cancer risk: international meta-analysis of 684,660 men with vasectomies

  Randall S, Boyd J, Fuller E, Brooks C, Morris C, Earle CC, Ferrante A, Moorin R, Semmens J, Holman CDJ. J Urol. 2018; 200(1):121-5. Epub 2018 Mar 7.

• The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies

  Klaassen Z, Wallis CJD, Goldberg H, Chandrasekar T, Sayyid RK, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P, Kulkarni GS. Br J Cancer. 2019; 120(8):840-7. Epub 2019 Mar 5. DOI: 10.1038/s41416-019-0390-0.

• Management of cancer-associated intestinal obstruction in the final year of life

  Merchant SJ, Brogly SB, Booth CM, Goldie C, Peng Y, Nanji S, Patel SV, Lajkosz K, Baxter NN. J Palliat Care. 2019; Jul 16 [Epub ahead of print]. DOI: 10.1177/0825859719861935.

• Regional variation in the management of metastatic gastric cancer in Ontario

  Mahar AL, Coburn NG, Kagedan DJ, Viola R, Johnson AP. Curr Oncol. 2016: 23(4):250-7. Epub 2016 Aug 12.

• Association between metformin use and mortality after cervical cancer in older women with diabetes

  Han K, Pintilie M, Lipscombe LL, Lega IC, Milosevic MF, Fyles AW. Cancer Epidemiol Biomarkers Prev. 2016; 25(3):507-12. Epub 2015 Dec 31.

• End of life care for women with gynecologic cancers

  Barbera L, Elit L, Krzyzanowska M, Saskin R, Bierman AS. Gynecol Oncol. 2010; 118(2):196-201. Epub 2010 May 13.

• Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?

  Booth CM, Karim S, Brennan K, Siemens DR, Peng Y, Mackillop WJ. Urol Oncol. 2018; 36(3):89.e13-89.e20. Epub 2017 Dec 15.

• Management of stage III colon cancer in the elderly: practice patterns and outcomes in the general population

  Merchant SJ, Nanji S, Brennan K, Karim S, Patel SV, Biagi JJ, Booth CM. Cancer. 2017; 123(15):2840-9. Epub 2017 Mar 27.

• Predictors of and trends in high-intensity end-of-life care among children with cancer: a population-based study using health services data

  Kassam A, Sutradhar R, Widger K, Rapoport A, Pole JD, Nelson K, Wolfe J, Earle CC, Gupta S. J Clin Oncol. 2017; 35(2):236-42. Epub 2016 Nov 16.

• Is there a sex effect in colon cancer? Disease characteristics, management, and outcomes in routine clinical practice

  Quirt JS, Nanji S, Wei X, Flemming JA, Booth CM. Curr Oncol. 2017; 24(1):e15-23.

• Risk factors for breast cancer mortality among the National Breast Screening Study of Canada participants

  Busetti MC, Miller AB, To T, Rohan TE. Cancer Detect Prev. 1996; 20(2):122-9.

• Metformin use and kidney cancer outcomes in patients with diabetes: a propensity score analysis

  Nayan M, Finelli A, Jewett MA, Juurlink DN, Austin PC, Kulkarni GS, Hamilton RJ. Clin Genitourin Cancer. 2017; 15(2):300-5. Epub 2016 Jun 23.

• Population-based longitudinal study of follow-up care for breast cancer survivors

  Grunfeld E, Hodgson DC, Del Giudice ME, Moineddin R. J Oncol Pract. 2010; 6(4):174-81.

• Financial incentives and cervical cancer screening participation in Ontario’s primary care practice models

  Pendrith C, Thind A, Zaric GS, Sarma S. Healthc Policy. 2016; 12(1):116-28.

• Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis

  Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Gastroenterology. 2007; 132(1):96-102.

• Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer

  Wallis CJ, Cheung P, Herschorn S, Saskin R, Su J, Klotz LH, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK. Br J Cancer. 2015; 112(6):977-82. Epub 2015 Feb 17.

• Trends over time in the use of laparoscopic hysterectomy for the treatment of endometrial cancer

  Kroft J, Li Q, Saskin R, Elit L, Bernardini MQ, Gien LT. Gynecol Oncol. 2015; 138(3):536-41. Epub 2015 Jul 11.

• Fractionation in adjuvant radiotherapy for invasive breast cancer and ductal carcinoma in situ in Ontario, Canada from 2009 to 2015

  Chan S, Sutradhar R, Yao Z, Chow E, Lee J, Wan BA, Paszat L. Breast J. 2019; Sep 12 [Epub ahead of print]. DOI: 10.1111/tbj.13515.

• Increased risk of all cardiovascular disease subtypes among childhood cancer survivors: population-based matched cohort study

  Khanna A, Pequeno P, Gupta S, Thavendiranathan P, Lee DS, Abdel-Qadir H, Nathan PC. Circulation. 2019; 140(12):1041-3. Epub 2019 Aug 26. DOI: 10.1161/CIRCULATIONAHA.119.041403.

• Phase-specific health care costs of cervical cancer: estimates from a population-based study

  Liu N, Mittmann N, Coyte PC, Hancock-Howard R, Seung SJ, Earle CC. Am J Obstet Gynecol. 2016; 214(5):615.e1-11. Epub 2015 Nov 25.

• Risk of colorectal cancer among immigrants to Ontario, Canada

  Paszat L, Sutradhar R, Liu Y, Baxter NN, Tinmouth J, Rabeneck L. BMC Gastroenterol. 2017; 17(1):85.

• Concurrent chemoradiotherapy for bladder cancer: practice patterns and outcomes in the general population

  Ghate K, Brennan K, Karim S, Siemens DR, Mackillop WJ, Booth CM. Radiother Oncol. 2018; 127(1):136-42. Epub 2018 Jan 3.

• Breast cancer therapy-related cardiac dysfunction in adult women treated in routine clinical practice: a population-based cohort study

  Thavendiranathan P, Abdel-Qadir H, Fischer HD, Camacho X, Amir E, Austin PC, Lee DS. J Clin Oncol. 2016; 34(19):2239-46. Epub 2016 Apr 18.

• Surveillance mammography after treatment of primary breast cancer: a systematic review

  Grunfeld E, Noorani H, McGahan L, Paszat L, Coyle D, van Walraven C, Joyce J, Sawka C. Breast. 2002; 11(3):228-35.

• Development of an instrument to measure cancer screening knowledge, attitudes and behaviours

  Kindree T, Ashbury FD, Goel V, Levy I, Lipskie T, Futcher R. Chronic Dis Can. 1997; 18(4):168-75.

• Towards further understanding of prognostic factors for head and neck cancer patients: the example of hypopharyngeal cancer

  Hall SP, Groome PA, Irish J, O'Sullivan B. Laryngoscope. 2009; 119(4):696-702.

• The association between continuity of primary care and preventive cancer screening in women with intellectual disabilities

  Plourde N, Brown HK, Vigod S, Cobigo V. Am J Intellect Dev Disabil. 2018; 123(6):499-513. Epub 2018 Nov 1.

• The generation of two specific cancer costing algorithms using Ontario administrative databases

  Mittmann N, Cheng SY, Liu N, Seung SJ, Saxena FE, DeAngelis C, Look Hong NJ, Earle CC, Cheung MC, Leighl N, Coburn N, Evans WK. Curr Oncol. 2019; 26(5):e682-92. Epub 2019 Oct 1. DOI: https://doi.org/10.3747/co.26.5279

• Using performance status to guide initiation of palliative care support among patients with cancer

  Sutradhar R. Healthc Q. 2015; 18(2):7-9.

• Medication use and survival in diabetic patients with kidney cancer: a population-based cohort study

  Nayan M, Macdonald EM, Juurlink DN, Austin PC, Finelli A, Kulkarni GS, Hamilton RJ; Canadian Drug Safety and Effectiveness Research Network (CDSERN). Pharmacol Res. 2016; 113(2016):468-74. Epub 2016 Sep 24.

• Long-term risk of thyroid cancer after initially negative thyroid biopsy results

  Bongers PJ, Kluijfhout WP, Devon K, Rotstein LE, Vriens MR, Urbach DR, Pasternak JD. JAMA Otolaryngol Head Neck Surg. 145(6):579-80. Epub 2019 Apr 18. DOI: 10.1001/jamaoto.2019.0386.

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• »